Management and outcomes of proteasome inhibitor associated chalazia and blepharitis: a case series

Conservative therapy for chalazia: is it really effective?

(2018) Albert Y Wu et al.   ACTA OPHTHALMOLOGICA

Treatment With Doxycycline for Severe Bortezomib-Associated Blepharitis

(2016) Marie-Charlotte Veys et al.   Clinical Lymphoma Myeloma & Leukemia

Association Between Bortezomib Therapy and Eyelid Chalazia

(2016) Frederick W. Fraunfelder et al.   JAMA Ophthalmology

Medical management of blepharitis

(2015) Katherine Duncan et al.   CURRENT OPINION IN OPHTHALMOLOGY

Chalazia Associated with Bortezomib Therapy for Multiple Myeloma

(2014) Seanna R. Grob et al.   OPHTHALMOLOGY

Proteasome inhibitor MG132 induces NAG-1/GDF15 expression through the p38 MAPK pathway in glioblastoma cells

(2012) Sachie Shimizu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The novel JAK inhibitor CYT387 suppresses multiple signalling pathways, prevents proliferation and induces apoptosis in phenotypically diverse myeloma cells

(2011) K A Monaghan et al.   LEUKEMIA

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

(2010) Annemiek Broyl et al.   LANCET ONCOLOGY